Last updated on October 2018

A Randomized Pivotal Study of RenewTM NCP-5 for the Treatment of Mild Cognitive Impairment due to Alzheimer’s Disease or Mild Dementia of the Alzheimer’s Type


Brief description of study

RenewTM NCP-5, an ECP device, is a non-invasive treatment that improves coronary and peripheral vascular health and may improve cerebral vascular health. It enhances circulation and stimulates endothelial production of trophic factors such as nitric oxide, resulting in peripheral vasodilation, reduction in vascular inflammation and improved vascular compliance. These and other factors result in increased coronary artery blood flow, reduced cardiac afterload and reduced systemic blood pressure.

 

Clinical Study Identifier: TX213549

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.